Impact of reduced mycophenolate exposure on chronic lung allograft dysfunction incidence after lung transplant
In our cohort, most LTRs had an MMF dose modification within 36 months, yet CLAD incidence was consistent with rates reported in the ISHLT Thoracic Organ Transplant Registry. In contrast, more patients demonstrated reduced allograft function compared to post-TXP peak, consistent with "potential" CLAD.
Authors
- Kaitlyn Grieves
- Brian C. Keller (ORCID: https://orcid.org/0000-0003-2997-6712)
- G. Waldman (ORCID: https://orcid.org/0000-0003-3291-4491)
- Jacqueline Clark
Institutions
- Massachusetts General Hospital (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1016/j.jhlto.2024.100156
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00